Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta -dihydroxy5-(1-methylethyl)-3-phenyl-4-[(phenyla mino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide

Details for Australian Patent Application No. 2002232891 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Niddam-Hildesheim, Valerie; Lifshitz, Revital; Lidor-Hadas, Ramy; Ishai, Eti

Agent Shelston IP

Pub. Number AU-B-2002232891

PCT Pub. Number WO02/43667

Priority 60/249,319 16.11.00 US; 60/326,529 01.10.01 US; 60/312,144 13.08.01 US

Filing date 24 October 2001

Wipo publication date 11 June 2002

Acceptance publication date 14 December 2006

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07B 53/00 (2006.01) Asymmetric syntheses

C07B 61/00 (2006.01) Other general methods

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

14 December 2006 Application Accepted

  Published as AU-B-2002232891

19 April 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002232892-Method and device for selectively targeting cells within a three -dimensional specimen

2002232890-CATHETER WITH ENHANCED REINFORCEMENT